Millipore Sigma Vibrant Logo

MABN2295 Anti-Amyloid beta A4 protein Antibody, clone 2E9

View This Product on Sigma-Aldrich
MABN2295
100 μg  
Retrieving price...
Price could not be retrieved
Minimum Quantity is a multiple of
Maximum Quantity is
Upon Order Completion More Information
You Saved ()
 
Request Pricing
Limited Availability
Limited Availability
In Stock 
Discontinued
Limited Quantities Available
Availability to be confirmed
    Remaining : Will advise
      Remaining : Will advise
      Will advise
      Contact Customer Service
      Contact Customer Service

       

      Contact Customer Service

      Overview

      Replacement Information

      Key Spec Table

      Species ReactivityKey ApplicationsHostFormatAntibody Type
      M, HIP, WB, IFRPurifiedMonoclonal Antibody
      Description
      Catalogue NumberMABN2295
      DescriptionAnti-Amyloid beta A4 protein Antibody, clone 2E9
      Alternate Names
      • ABPP
      • APPI
      • APP
      • APP
      • Alzheimer disease amyloid protein
      • Amyloid precursor protein
      • Beta-amyloid precursor protein
      • Cerebral vascular amyloid peptide
      • CVAP
      • PreA4
      • Protease nexin-II
      • PN-II
      Background InformationAmyloid beta A4 protein (UniProt: P05067; also known as ABPP, APPI. APP, APP, Alzheimer disease amyloid protein, Amyloid precursor protein, Beta-amyloid precursor protein, Cerebral vascular amyloid peptide, CVAP, PreA4, Protease nexin-II, PN-II) is encoded by the APP (also known as A4, AD1) gene (Gene ID: 351) in human. Deposition of Amyloid beta (Ab) is an early event in the pathogenesis of Alzheimer s disease (AD). Ab peptides originate from the proteolytic cleavage of the amyloid precursor protein (APP). APPs are cell surface protein that are internalized via clathrin-coated pits. During maturation, the immature APP (N-glycosylated in the endoplasmic reticulum) moves to the Golgi complex where complete maturation occurs (O-glycosylated and sulfated). After alpha-secretase cleavage, soluble APP is released into the extracellular space and the C-terminal is internalized to endosomes and lysosomes. The beta-secretase cleaves APP between residues Met671 and Asp672 and yields sAPP beta and C99. Following the beta-secretase cleavage, a second cleavage occurs at the C-terminus of Ab peptide that releases Ab from C99. This cleavage occurs in the vicinity of residue 712 of the C-terminus. The gamma-secretase can cleave the C-terminal region at either Val711 or Ile713 to produce the shorter Ab peptide (Ab1-40) or the longer Ab peptide (Ab1-42). Ab1-42 occurs more frequently and forms fibrillar aggregates far more readily than the Ab1-40 peptide. Beta-amyloid peptides are lipophilic metal chelators with metal-reducing activity. Bind transient metals such as copper, zinc and iron. In vitro, can reduce Cu2+ and Fe3+ to Cu+ and Fe2+, respectively. Abeta42 is a more effective reductant than beta-amyloid 40. From a physiological point of view, it functions on the surface of neurons relevant to neurite growth, neuronal adhesion and axonogenesis. It is also involved in cell mobility and transcription regulation through protein-protein interactions and can promote transcription activation through binding to APBB1-KAT5.
      References
      Product Information
      FormatPurified
      PresentationPurified rat monoclonal antibody IgG2a in buffer containing 0.1 M Tris-Glycine (pH 7.4), 150 mM NaCl with 0.05% sodium azide.
      Quality LevelMQ100
      Applications
      ApplicationAnti-Amyloid beta A4 protein, clone 2E9 Antibody, Cat. No. MABN2295, is a highly specific rat monoclonal antibody that targets Amyloid beta A4 protein and has been tested in Immunofluorescence, Immunoprecipitation, and Western Blotting.
      Key Applications
      • Immunoprecipitation
      • Western Blotting
      • Immunofluorescence
      Application NotesWestern Blotting Analysis: 0.5 µg/mL from a representative lot detected Amyloid beta A4 protein in 10 µg of N2a, N2aA, and N2aAB cell lysate.

      Immunofluorescence Analysis: A representative lot detected Amyloid beta A4 protein in Immunofluorescence applications (Willem, M., et. al. (2015). Nature. 526(7573):443-7).

      Western Blotting Analysis: A representative lot detected Amyloid beta A4 protein in Western Blotting applications (Willem, M., et. al. (2015). Nature. 526(7573):443-7).

      Immunoprecipitation Analysis: A representative lot detected Amyloid beta A4 protein in Immunoprecipitation applications (Willem, M., et. al. (2015). Nature. 526(7573):443-7).
      Biological Information
      ImmunogenKLH-conjugated linear peptide corresponding to 11 amino acids from the C-terminal half of human Amyloid beta A4 protein (APP770).
      Clone2E9
      ConcentrationPlease refer to lot specific datasheet.
      HostRat
      SpecificityClone 2E9 detects multiple isoforms of APP. It targets a sequence of 11 amino acids in the C-terminal region.
      IsotypeIgG2aκ
      Species Reactivity
      • Mouse
      • Human
      Species Reactivity NoteHuman, Mouse.
      Antibody TypeMonoclonal Antibody
      Entrez Gene Number
      Gene Symbol
      • APP
      • A4
      • AD1
      Purification MethodProtein G purified
      UniProt Number
      Molecular Weight~110 kDa observed. Calculated 86.94 kDa for APP770, 78.66 kDa for APP695. Uncharacterized bands may be observed in some lysate(s).
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Quality AssuranceEvaluated by Western Blotting in human Ntera-2 cell lysate.

      Western Blotting Analysis: 0.5 ug/mL of this antibody detected Amyloid beta A4 protein in 10 µg of human Ntera-2 cell lysate
      Usage Statement
      • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
      Storage and Shipping Information
      Storage ConditionsStable for 1 year at 2-8°C from date of receipt.
      Packaging Information
      Material Size100 μg
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Catalogue Number GTIN
      MABN2295 04054839189197